Literature DB >> 3968758

Adrenergic and non-adrenergic contraction of isolated urethral muscle from rabbit and man.

A Mattiasson, K E Andersson, C Sjögren.   

Abstract

Isolated urethral muscle from rabbit and man was subjected to electrical field stimulation and the components of the resulting contraction were analyzed. Contraction usually consisted of 2 main components. One was rapidly developing, non-adrenergic and atropine-resistant. The other developed more slowly and was sensitive to alpha-adrenoceptor blockade and to chemical sympathectomy with 6-hydroxydopamine. By lowering the temperature from 37C to 20C, these contraction components could be separated from each other. Both could be blocked by tetrodotoxin but the effects of this drug were not consistent in human tissue. Characteristic for the initial contraction component was its dependence on the tension of the preparation; it increased with increasing tension. The adrenergic part of the contraction could be effectively blocked by phentolamine and prazosin, whereas rauwolscine was less effective. Atropine and scopolamine also inhibited the adrenergic part of the contraction, whereas acetylcholine caused a transient increase. The non-adrenergic contraction component was less sensitive to deprivation of extracellular Ca2+ than the adrenergic; almost 40 per cent remained after exposure to Ca2+ free solution for 40 min., whereas the adrenergic component disappeared after 20 min. exposure. Light and electron microscopic investigation revealed 3 distinct layers of the rabbit urethral wall, 1 outer consisting of smooth and striated muscle, 1 middle consisting of smooth muscle only, and a submucosal layer where vessels and smooth muscle cells were found. Removal of the longitudinal muscle layer did not change the responses to electrical stimulation. The results suggest that the electrically induced adrenergic activation of urethral muscle of both rabbit and man was mediated mainly via alpha-adrenoceptors and that this muscle is innervated not only by sympathetic, adrenergic nerves but also by a type of nerve able to release a non-cholinergic, contraction-mediating transmitter.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3968758     DOI: 10.1016/s0022-5347(17)48927-0

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  5 in total

1.  Receptor function studies in specimens from the proximal human urethra obtained by transurethral resection.

Authors:  P Amark; A C Kinn; A Nergårdh
Journal:  Urol Res       Date:  1992

2.  Direct effect of amezinium on rabbit urethra: effect of estrogen and progesterone treatment.

Authors:  M Ishigooka; T Hashimoto; Y Suzuki; O Ichiyanagi; I Sasagawa; T Nakada
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1996

3.  Is there a peripheral site of action contributing to the voiding effects of α₂-adrenoceptor agonists and antagonists?

Authors:  Erik Aro; Sanna Bastman; Karl-Erik Andersson; Tomi Streng
Journal:  World J Urol       Date:  2014-06-07       Impact factor: 4.226

Review 4.  The role of vasoactive intestinal polypeptide and pituitary adenylate cyclase-activating polypeptide in the neural pathways controlling the lower urinary tract.

Authors:  Mitsuharu Yoshiyama; William C de Groat
Journal:  J Mol Neurosci       Date:  2008-08-02       Impact factor: 3.444

5.  Changes in nerve-mediated contractility of the lower urinary tract in a mouse model of premature ageing.

Authors:  D Triguero; A Lafuente-Sanchis; A Garcia-Pascual
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.